Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.

Jonathan Chang // Publications // Jul 01 2018

PubMed ID: 29571831

Author(s): Yannuzzi NA, Sridhar J, Chang JS, Lin J, Kuriyan AE, Smiddy WE. Cost evaluation of laser versus intravitreal aflibercept for proliferative diabetic retinopathy. Ophthalmology. 2018 Jul;125(7):1121-1122. doi: 10.1016/j.ophtha.2018.02.019. Epub 2018 Mar 20. PMID 29571831

Journal: Ophthalmology, Volume 125, Issue 7, 07 2018